Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

about

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

Item

http://www.wikidata.org/entity/Q55710797

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@en

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@nl

type

Item

label

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@en

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@nl

prefLabel

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@en

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

@nl

P1476

Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer

@en

P2093

David Parker

http://www.w3.org/2001/XMLSchema#string

Eva J Gordon

http://www.w3.org/2001/XMLSchema#string

Jennifer Pena

http://www.w3.org/2001/XMLSchema#string

Julia A Elvin

http://www.w3.org/2001/XMLSchema#string

Kelly Barth

http://www.w3.org/2001/XMLSchema#string

Nina J Karlin

http://www.w3.org/2001/XMLSchema#string

Thomas DeLeon

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms.

Activated RET and ROS: two new driver mutations in lung adenocarcinoma.

Lung cancer, thyroid cancer or both: An unusual case presentation.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

Thyroid carcinoma: molecular pathways and therapeutic targets

Metastatic patterns of cancers: results from a large autopsy study.

RET revisited: expanding the oncogenic portfolio.

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.

Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.

P304

399-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000490238

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30022943

http://www.w3.org/2001/XMLSchema#string

P932

6047557

http://www.w3.org/2001/XMLSchema#string